On February 19, 2026, Charles & Colvard, Ltd. approved a reimbursement of $406,188.72 for expenses incurred by Riverstyx Fund, LP, associated with a proxy solicitation for the 2025 Annual Meeting. The decision was made with disinterested Board members and will be deferred until the company is in a stronger financial position.